Novo Nordisk A/S – Page 2 – Today Stock Markets News

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

Wall Street deals 2025 under Trump: Tariffs, uncertainty slow M&A

Nine pharma companies ink deals with Trump to lower drug prices

Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Eli Lilly cuts cash prices of Zepbound weight loss drug vials

Eli Lilly hits $1 trillion market value, first for health care company

Novo Nordisk cuts cash prices for Wegovy, Ozempic

Stoxx 600, Fed cut, AI bubble, China economy

Trump strikes deal with Eli Lilly, Novo Nordisk